Tumor progression can be promoted by these factors through various mechanisms, including IFNγ and IL-17 mediated tumor immune surveillance or the recruitment of immune cells into the tumor microenvironment via TNF-α, IL-1β, and IL-6 [28]. The gene discussed is IL6; the disease is neoplasm.